Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase

This publication has 64 references indexed in Scilit:

• Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells
  Cancer Gene Therapy, 2001
• Generation of Dual Resistance to 4-Hydroperoxycyclophosphamide and Methotrexate by Retroviral Transfer of the Human Aldehyde Dehydrogenase Class 1 Gene and a Mutated Dihydrofolate Reductase Gene
  Molecular Therapy, 2001
• Expression of a Novel Double-Mutant Dihydrofolate Reductase-Cytidine Deaminase Fusion Gene Confers Resistance to Both Methotrexate and Cytosine Arabinoside
  Human Gene Therapy, 1999
• Effect of Cyclin D1 Overexpression on Drug Sensitivity in a Human Fibrosarcoma Cell Line
  JNCI Journal of the National Cancer Institute, 1996
• Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.
  Journal of Clinical Investigation, 1994
• Gene therapy utilizing drug resistance genes: A review
  The International Journal of Cell Cloning, 1994
• Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
  Published by Elsevier ,1992
• Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
  Cell, 1992
• The Pharmacology and Clinical Use of Methotrexate
  New England Journal of Medicine, 1983
• Unstable Methotrexate Resistance in Human Small-Cell Carcinoma Associated with Double Minute Chromosomes
  New England Journal of Medicine, 1983